Moderna and Pfizer Clash Over Trial Date in COVID-19 Vaccine Patent Dispute

Vaccine behemoths Moderna and Pfizer are currently in a deadlock over establishing a trial date concerning COVID-19 vaccine patent infringement claims in Massachusetts federal court. Pfizer’s preference leans toward scheduling a trial post the decision of summary judgment motions, while Moderna on the other hand advocates for the urgent need of establishing a fixed trial date – aiming for this forthcoming autumn. The ripple effects of this dispute could send shockwaves through both the legal and pharmaceutical communities, albeit it remains unclear when the gavel will strike.

For more detailed information, you can read the original news here.